PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Financial Results for Fiscal 2016 and Its Quarterly Dividend Raised to $0.19 Per Share


Fourth Quarter New Order Sales Increased 24%
Fourth Quarter Sales Increased 11%
Fourth Quarter Net Income Increased 9.4%

POMPANO BEACH, Fla., May 09, 2016 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the fiscal year ended March 31, 2016.  Net sales for the quarter ended March 31, 2016 were $55.4 million, compared to $50.0 million for the quarter ended March 31, 2015, an increase of 11%.  For the fiscal year ended March 31, 2016 net sales were $234.7 million, compared to $229.4 million for the fiscal year ended March 31, 2015, an increase of 2.3%.  The increase in sales for the quarter ended March 31, 2016 can be attributed to a 24% increase in new order sales, and an 8.4% increase in reorder sales.  Net income for the quarter ended March 31, 2016 was $5.4 million, or $0.27 diluted per share, compared to net income of $5.0 million, or $0.25 diluted per share, for the same quarter the prior year, an increase to net income of 9.4%.  Excluding a one-time charge for an IT-related discontinued project in the quarter ended September 30, 2014, net income for the fiscal year ended March 31, 2016 was $20.6 million, or $1.02 diluted per share, compared to net income of $18.5 million, or $0.92 diluted per share, for the fiscal year ended March 31, 2015, an increase to net income of 11%.  The one-time IT-related discontinued project cost of $1.7 million was expensed in fiscal 2015, and the after tax net impact of this charge was $1.1 million, or $0.05 diluted per share.  The Company’s online sales for the quarter ended March 31, 2016 were approximately 82% of all sales, compared to 81% for the same quarter the prior year.

Menderes Akdag, President and CEO, commented: “We saw sharp increases in both new order and reorder sales, helped in part by the unseasonably warmer weather in the March quarter.  We were encouraged with our advertising efficiency in the quarter, as our new customer acquisition costs were reduced to $32 for the quarter ended March 31, 2016 compared to $42 for the same quarter the prior year. During the March quarter we acquired approximately 116,000 new customers, compared to 97,000 new customers acquired in the same quarter the prior year.  Average order value was $83 for the March quarter compared to $81 for the same quarter the prior year. For the quarter ended March 31, 2016 our operating expenses decreased by about 185 basis points, which can be attributed to a reduction in advertising spending and the leveraging of our general and administrative expenses.  In fiscal 2017, we will be preparing to move into our new corporate headquarters and distribution facility, which is expected to occur in our third fiscal quarter.”

The Board of Directors declared an increased quarterly dividend of $0.19 per share on its common stock.  The dividend will be payable on May 27, 2016, to shareholders of record at the close of business on May 20, 2016.  The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the year-end financial results.  To access the call which is open to the public, dial (888) 455-1758 (toll free) or (203) 827-7025.  Callers will be required to supply PETMEDS as the passcode.  For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on May 9, 2016 until May 23, 2016 at 11:59 P.M.  To access the replay, call (800) 879-6405 (toll free) or (402) 220-4745 and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.  This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan.  Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2015.  The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K. 

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

PETMED EXPRESS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands)
 
   March 31,  March 31, 
   2016  2015 
        
ASSETS       
        
Current assets:       
Cash and cash equivalents $37,639 $35,613 
Short term investments - available for sale  -  15,591 
Accounts receivable, less allowance for doubtful      
accounts of $13 and $8, respectively  1,724  1,931 
Inventories - finished goods  25,586  25,068 
Prepaid expenses and other current assets  2,435  1,380 
Prepaid income taxes  243  - 
Total current assets  67,627  79,583 
       
Noncurrent assets:      
Property and equipment, net  20,929  1,569 
Intangible assets  860  860 
Deferred tax assets  863  840 
Total noncurrent assets  22,652  3,269 
        
Total assets $90,279 $82,852 
        
LIABILITIES AND SHAREHOLDERS' EQUITY      
       
Current liabilities:      
Accounts payable $5,004 $5,153 
Accrued expenses and other current liabilities  2,080  2,214 
Income taxes payable  -  50 
        
Total liabilities  7,084  7,417 
        
Commitments and contingencies      
       
Shareholders' equity:      
Preferred stock, $.001 par value, 5,000 shares authorized;      
3 convertible shares issued and outstanding with a      
liquidation preference of $4 per share  9  9 
Common stock, $.001 par value, 40,000 shares authorized;      
20,447 and 20,262 shares issued and outstanding, respectively  20  20 
Additional paid-in capital  4,871  3,117 
Retained earnings  78,295  72,343 
Accumulated other comprehensive loss  -  (54)
        
Total shareholders' equity  83,195  75,435 
        
Total liabilities and shareholders' equity $90,279 $82,852 
        


PETMED EXPRESS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands, except for per share amount)
           
  Three Months Ended Year Ended
  March 31, March 31,
   2016    2015   2016    2015 
               
  (UNAUDITED)     
Sales$ 55,392  $ 49,994 $ 234,684  $ 229,395 
Cost of sales  37,729    33,055   158,388    153,125 
           
Gross profit  17,663    16,939   76,296    76,270 
           
Operating expenses:          
General and administrative  5,137    4,899   21,301    21,101 
Advertising  3,715    4,048   21,837    25,182 
Discontinued project costs  -    -   -    1,714 
Depreciation  226    173   770    660 
Total operating expenses  9,078    9,120   43,908    48,657 
           
Income from operations  8,585    7,819   32,388    27,613 
           
Other income (expense):          
Interest income, net  30    46   190    184 
Realized loss on sale of short term investments (74)   -   (74)   - 
Other, net  75    (2)  63    1 
Total other income  31    44   179    185 
           
Income before provision for income taxes  8,616    7,863   32,567    27,798 
           
Provision for income taxes  3,198    2,912   12,000    10,345 
           
Net income$ 5,418  $ 4,951   20,567  $ 17,453 
           
Net change in unrealized gain (loss)          
on short and long term investments  87    (4)  54    (17)
           
Comprehensive income$ 5,505  $ 4,947 $ 20,621  $ 17,436 
           
Net income per common share:          
Basic$ 0.27  $ 0.25 $ 1.02  $ 0.87 
Diluted$ 0.27  $ 0.25 $ 1.02  $ 0.87 
           
Weighted average number of common shares outstanding:        
Basic  20,152    20,044   20,124    20,015 
Diluted  20,322    20,146   20,254    20,136 
           
Cash dividends declared per common share$ 0.18  $ 0.17 $ 0.72  $ 0.68 
           


PETMED EXPRESS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
    
    Year Ended 
    March 31, 
   2016   2015 
Cash flows from operating activities:      
Net income $20,567  $17,453 
Adjustments to reconcile net income to net cash      
provided by operating activities:      
Depreciation  770   660 
Share based compensation  1,612   1,481 
Discontinued project costs  -   1,714 
Deferred income taxes  (23)  157 
Bad debt expense  260   94 
(Increase) decrease in operating assets      
and increase (decrease) in liabilities:      
Accounts receivable  (53)  (264)
Inventories - finished goods  (518)  10,659 
Prepaid income taxes  (243)  54 
Prepaid expenses and other current assets  (1,055)  662 
Accounts payable  (149)  (616)
Accrued expenses and other current liabilities  (65)  (61)
Income taxes payable  (50)  50 
Net cash provided by operating activities  21,053   32,043 
         
Cash flows from investing activities:      
Proceeds from the sale of short term investments  15,591   - 
Net change in investments  54   (68)
Purchases of property and equipment  (20,130)  (918)
Net cash used in investing activities  (4,485)  (986)
         
Cash flows from financing activities:      
Dividends paid  (14,684)  (13,807)
Tax adjustment related to stock compensation  142   58 
Net cash used in financing activities  (14,542)  (13,749)
         
Net increase in cash and cash equivalents  2,026   17,308 
Cash and cash equivalents, at beginning of year  35,613   18,305 
         
Cash and cash equivalents, at end of year $37,639  $35,613 
         
Supplemental disclosure of cash flow information:        
         
Cash paid for income taxes $12,173  $10,026 
         
Dividends payable in accrued expenses $143  $212